HomeUstekinumab AeknUstekinumab Aekn + Allergen Immunotherapy

Does Ustekinumab Aekn Interact with Allergen Immunotherapy?

Ustekinumab Aekn and Allergen Immunotherapy have a moderate drug interaction according to U.S. FDA drug labeling data. Ustekinumab may decrease the protective effect of allergen immunotherapy and increase risk of allergic reaction. Caution should be exercised, particularly regarding anaphylaxis risk. The mechanism involves immunosuppressive mechanism may decrease tolerance to allergen immunotherapy. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Moderate
Ustekinumab Aekn Class
Interleukin-12 Antagonist
Management
Monitor for effects
Data Source
U.S. FDA via OpenFDA

How This Interaction Works

The interaction between Ustekinumab Aekn and Allergen Immunotherapy occurs because immunosuppressive mechanism may decrease tolerance to allergen immunotherapy. Clinically, this means ustekinumab may decrease the protective effect of allergen immunotherapy and increase risk of allergic reaction. caution should be exercised, particularly regarding anaphylaxis risk. This is classified as a moderate interaction. While it may not require stopping either medication, your healthcare provider should be aware you are taking both so they can monitor for potential effects and adjust treatment if necessary.

What To Tell Your Doctor or Pharmacist

If you are taking Ustekinumab Aekn and your doctor is considering prescribing Allergen Immunotherapy (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Ask whether any dosage adjustments are needed
  • Never stop or change either medication without first consulting your healthcare provider
💊 Ustekinumab Aekn(Ustekinumab-Aekn)+💊 Allergen Immunotherapy

Severity & Interaction Details

🟡
moderate
Be aware — moderate interaction
Documented interaction with manageable risk. May require dose adjustment or monitoring.
Severity scale
MinorContra
On record
Yes
Drug A class
Interleukin-12 Antagonist
Drug B class
Source
NLP:ustekinumab-aekn

What this means in plain English

Ustekinumab may decrease the protective effect of allergen immunotherapy and increase risk of allergic reaction. Caution should be exercised, particularly regarding anaphylaxis risk.

What the FDA label says

"Immunosuppressive mechanism may decrease tolerance to allergen immunotherapy"

📖 Source: NLP:ustekinumab-aekn

Share this result:XFacebookWhatsAppReddit
Add more drugs
Check Ustekinumab Aekn and Allergen Immunotherapy against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine. For informational purposes only. Always consult your pharmacist or physician.